Fidelity Investments
PLSE icon

Fidelity Investments’s Pulse Biosciences PLSE Stock Holding History

Fidelity Investments’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Buy
14,150
+11
+0.1% +$203 ﹤0.01% 3313
2025
Q4 		$194K Buy
14,139
+891
+7% +$13.9K ﹤0.01% 3455
2025
Q3 		$234K Buy
13,248
+700
+6% +$11.1K ﹤0.01% 3295
2025
Q2 		$189K Buy
12,548
+47
+0.4% +$780 ﹤0.01% 3327
2025
Q1 		$201K Sell
12,501
-282
-2% -$5.26K ﹤0.01% 3239
2024
Q4 		$223K Buy
12,783
+333
+3% +$5.87K ﹤0.01% 3227
2024
Q3 		$218K Buy
12,450
+45
+0.4% +$767 ﹤0.01% 3166
2024
Q2 		$139K Buy
12,405
+108
+0.9% +$1.02K ﹤0.01% 3171
2024
Q1 		$107K Sell
12,297
-169
-1% -$1.55K ﹤0.01% 3255
2023
Q4 		$153K Buy
12,466
+11,851
+1,927% +$82.1K ﹤0.01% 3044
2023
Q3 		$2.48K Buy
615
+592
+2,574% +$3.68K ﹤0.01% 4485
2023
Q2 		$165 Buy
+23
New +$147 ﹤0.01% 4924
2022
Q3 		– Sell
-176
Closed – – 5280
2022
Q2 		$0 Sell
176
-1,121
-86% -$2.82K ﹤0.01% 5362
2022
Q1 		$6K Buy
+1,297
New +$10.6K ﹤0.01% 4389

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Fidelity Investments's PLSE Position: Q1 2026 in Review

Fidelity Investments increased its Pulse Biosciences (PLSE) stake by 0.08% in Q1 2026, buying an estimated $203 and bringing the position to 14,150 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #3313.

Fidelity Investments first reported a position in PLSE in Q1 2022 and has held it in 14 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Fidelity Investments held 14,150 shares of Pulse Biosciences worth $305K as of Q1 2026.
  • Fidelity Investments bought 11 Pulse Biosciences shares in Q1 2026, an estimated $203.
  • Pulse Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3313 holding.
  • Fidelity Investments first reported a position in Pulse Biosciences in Q1 2022 and has held it in 14 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.